Syntax Research’s Thermo Fisher Scientific TMO Stock Holding History

Syntax Research’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Sell	2,210 -2,772	-56%	-$1.33M	0.81%	19
2026 Q1	$2.45M	Buy	4,982 +434	+10%	+$236K	1.56%	22
2025 Q4	$2.64M	Sell	4,548 -1,117	-20%	-$632K	1.63%	21
2025 Q3	$2.75M	Sell	5,665 -46	-0.8%	-$21.4K	1.77%	20
2025 Q2	$2.32M	Buy	5,711 +5,623	+6,390%	+$2.35M	1.64%	21
2025 Q1	$43.8K	Hold	88	–	–	0.03%	92
2024 Q4	$45.8K	Hold	88	–	–	0.03%	88
2024 Q3	$54.4K	Hold	88	–	–	0.04%	87
2024 Q2	$48.7K	Hold	88	–	–	0.04%	83
2024 Q1	$51.1K	Hold	88	–	–	0.04%	88
2023 Q4	$46.7K	Sell	88 -8	-8%	-$3.87K	0.04%	88
2023 Q3	$48.6K	Buy	+96	New	+$51.2K	0.04%	91

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Syntax Research's TMO Position: Q2 2026 in Review

Syntax Research reduced its Thermo Fisher Scientific (TMO) stake by 56% in Q2 2026, selling an estimated $1.33M and leaving 2,210 shares worth $1.11M. The position accounts for 0.81% of the portfolio, ranked #19.

Syntax Research first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.75M in Q3 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Syntax Research held 2,210 shares of Thermo Fisher Scientific worth $1.11M as of Q2 2026.
Syntax Research sold 2,772 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.33M.
Thermo Fisher Scientific made up 0.81% of Syntax Research's portfolio in Q2 2026, its #19 holding.
Syntax Research first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
Syntax Research's Thermo Fisher Scientific position peaked at $2.75M in Q3 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.